Can Chemotherapy Emerge From the Shadows in Resectable Cutaneous Squamous Cell Carcinoma?

Vasu Divi; A. Dimitrios Colevas

doi:10.1001/jamaoto.2025.2678

August 28, 2025JAMA Otolaryngology–Head & Neck Surgery

Can Chemotherapy Emerge From the Shadows in Resectable Cutaneous Squamous Cell Carcinoma?

View at Publisher

Ask AI

Bookmark

Share

Key Points

Chemotherapy may improve outcomes in patients with resectable cutaneous squamous cell carcinoma.
Evidence suggests that chemotherapy can be integrated into surgical treatment plans for better results.
Observational analysis highlights the need for a deeper exploration of chemotherapy in dermatological oncology.
The findings call for expanded research on chemotherapy's efficacy in skin cancer treatment pathways.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This analysis reveals chemotherapy's potential in enhancing treatment for cutaneous squamous cell carcinoma post-surgery, suggesting new therapeutic paths.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Divi et al. (2025) studied this question.

synapsesocial.com/papers/68bb3edf2b87ece8dc956d8e https://doi.org/10.1001/jamaoto.2025.2678

View at Publisher

Ask AI

Bookmark

Share

Can Chemotherapy Emerge From the Shadows in Resectable Cutaneous Squamous Cell Carcinoma?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Can Chemotherapy Emerge From the Shadows in Resectable Cutaneous Squamous Cell Carcinoma?

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading